FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Amerisource Health Services buPROPion Hydrochloride Extended-release Recall

buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Table…

Amerisource Health Services LLC · Columbus, OH

Risk level
Class II
Reported by FDA
Jul 17, 2024
Recall ID
D-0590-2024
Check your lot numberHow we source this data

Summary

Amerisource Health Services recalled buPROPion Hydrochloride Extended-release starting Jun 24, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0590-2024 on Jul 17, 2024. Reason: Failed Dissolution Specifications; the product is dissolving faster than the specified limits. Status: Ongoing.

Why it was recalled

Failed Dissolution Specifications; the product is dissolving faster than the specified limits.

Product description

buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC: 60687-782-01.

Lot numbers, UPCs & expiration codes

Lot 1017343, Exp. 12/31/2025

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0590-2024
Classification
Class II
Status
Ongoing
Recall initiated
Jun 24, 2024
FDA report date
Jul 17, 2024
Quantity
2,484 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Amerisource Health Services LLC

Original FDA data

Every field from FDA enforcement report D-0590-2024, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Ongoing
Country
United States
Event ID
94891
Address
2550 John Glenn Ave Ste A
Code information
Lot 1017343, Exp. 12/31/2025
Postal code
43217-1188
Report date
Jul 17, 2024
Product type
Drugs
Recall number
D-0590-2024
Classification
Class II
Recalling firm
Amerisource Health Services LLC
Product quantity
2,484 cartons
Reason for recall
Failed Dissolution Specifications; the product is dissolving faster than the specified limits.
Voluntary / mandated
Voluntary: Firm initiated
Product description
buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC: 60687-782-01.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jun 24, 2024
Initial firm notification
Letter
Center classification date
Jul 8, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0590-2024, published Jul 17, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls